Prevalence and predictors of multimodal treatment among US adults with ADHD

CONCLUSIONS: 25% of newly diagnosed ADHD adults received no treatment in 2021 and 53.7% only received a single-modality treatment – raising concerns about the potential implications of untreated ADHD on the persistence of ADHD-related impairments, morbidity, productivity, and downstream healthcare cost. The study also highlighted potential sociodemographic, clinical, and provider disparities in ADHD treatment.

via https://pubmed.ncbi.nlm.nih.gov/38000483/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20231126010807&v=2.17.9.post6+86293ac